SRA International, Inc. Awarded $17.9 Million Task Order to Continue Support of The Cancer Genome Atlas

FAIRFAX, Va.--(BUSINESS WIRE)--SRA International, Inc. (NYSE: SRX), a leading provider of technology and strategic consulting services and solutions to government organizations and commercial clients, today announced the award of a task order as a contractor to the National Institutes of Health (NIH) to continue bioinformatics support of the Data Coordinating Center (DCC) for The Cancer Genome Atlas (TCGA). The new award to SRA has a potential total dollar value of $17.9 million over five years, if all options are exercised.

Back to news